MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo

Nasopharyngeal carcinoma (NPC) is an endemic tumor with a relatively high incidence in Southern China and Southeast Asia. Paclitaxel combination chemotherapy has been used for treatment of advanced NPC. However, treatment failure often occurs due to development of acquired paclitaxel resistance. In...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Biol Ther
Main Authors: Peng, Xiaowei, Cao, Peiguo, Li, Jingjing, He, Dong, Han, Shuang, Zhou, Jianda, Tan, Guolin, Li, Wei, Yu, Fenghui, Yu, Jianjun, Li, Zan, Cao, Ke
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2015
Assuntos:
Research Papers
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4622873/
https://ncbi.nlm.nih.gov/pubmed/25756509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2014.1001287
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares